Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Le
Robert Quan
RQ
Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892-1202, USA.
Bevans
Margaret
M
Savani
Bipin N
BN
Mitchell
Sandra A
SA
Stringaris
Kate
K
Koklanaris
Eleftheria
E
Barrett
A John
AJ
D000293:Adolescent; D000328:Adult; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D017741:Survivors; D016896:Treatment Outcome; D055815:Young Adult